2 min Read

Biocon shares rise 5% after USFDA VAI approval

Biocon’s shares surged by 5% in early trade on November 11 following a significant regulatory update. The USFDA or Food and Drug Administration, granted Biocon's...

+91
Offer Banner Trigger
Offer Banner

Open a FREE Demat Account

+91